Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L S Williams

Showing results (81-90 of 85) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 85 results.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|January 1, 1995
AGN 191976: a novel thromboxane A2-mimetic with ocular hypotensive propertiesA H Krauss, D F Woodward, J Chen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 27, 2019
Are we assuming too much with our statistical assumptions? Lessons learned from the ALTTO trialE M Holmes, I Bradbury, L S Williams, et al.
British Journal of Pharmacology|March 1, 1996
Evidence for human thromboxane receptor heterogeneity using a novel series of 9,11-cyclic carbonate derivatives of prostaglandin F2 alphaA H Krauss, D F Woodward, L L Gibson, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 14, 2001
GABA(A) receptors containing (alpha)5 subunits in the CA1 and CA3 hippocampal fields regulate ethanol-motivated behaviors: an extended ethanol reward circuitryH L June, S C Harvey, K L Foster, et al.
The Pharmacogenomics Journal|August 9, 2017
Characterisation of the HLA-DRB1*07:01 biomarker for lapatinib-induced liver toxicity during treatment of early-stage breast cancer patients with lapatinib in combination with trastuzumab and/or taxanesC F Spraggs, L R Parham, L P Briley, et al.
Pageof 9

Showing results (81-90 of 85) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 85 results.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|January 1, 1995
AGN 191976: a novel thromboxane A2-mimetic with ocular hypotensive propertiesA H Krauss, D F Woodward, J Chen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 27, 2019
Are we assuming too much with our statistical assumptions? Lessons learned from the ALTTO trialE M Holmes, I Bradbury, L S Williams, et al.
British Journal of Pharmacology|March 1, 1996
Evidence for human thromboxane receptor heterogeneity using a novel series of 9,11-cyclic carbonate derivatives of prostaglandin F2 alphaA H Krauss, D F Woodward, L L Gibson, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 14, 2001
GABA(A) receptors containing (alpha)5 subunits in the CA1 and CA3 hippocampal fields regulate ethanol-motivated behaviors: an extended ethanol reward circuitryH L June, S C Harvey, K L Foster, et al.
The Pharmacogenomics Journal|August 9, 2017
Characterisation of the HLA-DRB1*07:01 biomarker for lapatinib-induced liver toxicity during treatment of early-stage breast cancer patients with lapatinib in combination with trastuzumab and/or taxanesC F Spraggs, L R Parham, L P Briley, et al.
Pageof 9